Outcome by Stroke Etiology in Patients Receiving Thrombolytic Treatment

Intravenous thrombolysis in patients with stroke attributable to small artery occlusion

(2010) F. Fluri et al.   EUROPEAN JOURNAL OF NEUROLOGY

Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials

(2010) Kennedy R Lees et al.   LANCET

Off-Label Thrombolysis Is Not Associated With Poor Outcome in Patients With Stroke

(2010) Atte Meretoja et al.   STROKE

The “Golden Hour” and Acute Brain Ischemia

(2010) Jeffrey L. Saver et al.   STROKE

Importance of Leukoaraiosis on CT for Tissue Plasminogen Activator Decision Making: Evaluation of the NINDS rt-PA Stroke Study

(2008) Andrew M. Demchuk et al.   CEREBROVASCULAR DISEASES

Early Neurological Deterioration following Intravenous Recombinant Tissue Plasminogen Activator Therapy in Patients with Acute Lacunar Stroke

(2008) Yang-Ha Hwang et al.   CEREBROVASCULAR DISEASES

Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke

(2008) Werner Hacke et al.   NEW ENGLAND JOURNAL OF MEDICINE